Search Knowledge Base

5 results for "venous-thromboembolism"

Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair pubmed_article
Evidence Source 2025 PMID: 39868562
Antithrombotic prophylaxis following total knee arthroplasty: a level I Bayesian network meta-analysis pubmed_article
Evidence Source 2024 PMID: 39126462
Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis pubmed_article
Evidence Source 2023 PMID: 36814196
Effectiveness and safety of non-vitamin K antagonist oral anticoagulant in the treatment of patients with morbid obesity or high body weight with venous thromboembolism: A meta-analysis pubmed_article
Evidence Source 2023 PMID: 37682131
Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis pubmed_article
Evidence Source 2014 PMID: 24996916

Evidence Search Results semantic · quality-ranked

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy meta_analysis pubmed_article
Quality: 74 2016 PMID: 27906452 DOI: 10.1002/14651858.CD008500.pub4
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy meta_analysis pubmed_article
Quality: 73 2020 PMID: 33337539 DOI: 10.1002/14651858.CD008500.pub5
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism meta_analysis pubmed_article
Quality: 73 2023 PMID: 37057837 DOI: 10.1002/14651858.CD010957.pub3
A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms meta_analysis pubmed_article
Quality: 66 2021 PMID: 33570633 DOI: 10.1182/bloodadvances.2020003628
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism meta_analysis cochrane_review
Quality: 79 2014 PMID: 25092359 DOI: 10.1002/14651858.CD001367.pub3
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy meta_analysis pubmed_article
Quality: 75 2012 PMID: 22336844 DOI: 10.1002/14651858.CD008500.pub2
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism meta_analysis pubmed_article
Quality: 74 2017 PMID: 29244199 DOI: 10.1002/14651858.CD011088.pub2
Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism meta_analysis pubmed_article
Quality: 71 2017 PMID: 28737834 DOI: 10.1002/14651858.CD002001.pub3
Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis meta_analysis pubmed_article
Quality: 62 2014 PMID: 24330006 DOI: 10.1111/jth.12485
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery systematic_review pubmed_article
Quality: 67 2015 PMID: 26091835 DOI: 10.1002/14651858.CD009658.pub2

View full evidence search →